Chinese herbal medicine for mild cognitive impairment using mini-mental state examination: A systematic review and

Wei Wang1, Yongchang Diwu, Qi Liu

  • 1Shaanxi University of Traditional Chinese Medicine, Xianyang, Shaanxi Province, China.

Medicine
|September 24, 2021
PubMed
Abstract

Insights

Chinese herbal medicine shows potential in improving cognitive scores for individuals with mild cognitive impairment (MCI). Further research is needed due to methodological limitations in current studies.

Area of Science:

  • Gerontology
  • Pharmacology
  • Integrative Medicine

Background:

  • Mild cognitive impairment (MCI) affects 6.7%–25.2% of the elderly population (60-84 years).
  • Preventing MCI progression to Alzheimer's disease (AD) is a critical health concern.
  • The Mini-Mental State Examination (MMSE) is a standard screening tool for cognitive function in Chinese clinics.

Purpose of the Study:

  • To evaluate the clinical impact of Chinese herbal medicines (CHMs) on MMSE scores in MCI patients.
  • To explore the pharmacological basis for CHMs' effectiveness in cognitive enhancement.

Main Methods:

  • Systematic review and meta-analysis of 21 studies from English and Chinese databases.
  • Risk of bias assessment using the Cochrane tool.
  • Statistical analyses including heterogeneity assessment, sensitivity analysis, and subgroup analysis.

Main Results:

  • Seventeen of the 21 studies favored CHM interventions.
  • CHMs demonstrated potential in improving MMSE scores among MCI patients.
  • Combination therapy of CHMs with other drugs showed significant MMSE score improvements.

Conclusions:

  • Herbal medicine shows promise for improving cognitive function in MCI patients.
  • CHMs, particularly in combination with other treatments, may significantly enhance MMSE scores.
  • Methodological limitations in existing studies necessitate further rigorous research.